The Microbe Discovery Project

A patient-led initiative supporting Dr. Ian Lipkin & Dr. Mady Hornig's ME/CFS research
at the Columbia University Center for Infection and Immunity, Mailman School of Public Health, New York.

A message from the Microbe Discovery Project

A message from the Microbe Discovery Project

Our Microbe Discovery Project patient team is now into our fourth year and we exist because high quality research into ME/CFS is desperately needed. We are now aware that Dr. Lipkin and Dr. Hornig are currently in a process of litigation. This is a very sad turn of events. However, we do not feel it is appropriate for us to comment on this otherRead more about A message from the Microbe Discovery Project[…]

Cort Johnson: Columbia & Simmaron Gut Study Uncovers Another ME/CFS Subset

Cort Johnson: Columbia & Simmaron Gut Study Uncovers Another ME/CFS Subset

Cort Johnson has done some serious homework on the recent gut microbiome study from Columbia University Center for Infection and Immunity (CII) researchers. He delves more deeply into the study and spoke with Dr. Ian Lipkin about their work. This article was originally published on the Simmaron Research website and Cort kindly gave us permission to publish the article in full for the Microbe Discovery Project. Columbia &Read more about Cort Johnson: Columbia & Simmaron Gut Study Uncovers Another ME/CFS Subset[…]

Ian Lipkin’s CII team shows gut bacteria in ME/CFS may influence disease severity

Ian Lipkin’s CII team shows gut bacteria in ME/CFS may influence disease severity

  Anticipated work from the CII teams’ early investigative research into ME/CFS is starting to be published. The new study in the journal Microbiome from Drs Ian Lipkin and Mady Horning at Columbia University Center for Infection and Immunity (CII) finds abnormal levels of certain types of bacteria in the gut microbiome of ME/CFS patients.Read more about Ian Lipkin’s CII team shows gut bacteria in ME/CFS may influence disease severity[…]

Cort Johnson: ‘Peterson’s Atypical Subset Opens New View of ME/CFS in Columbia/Simmaron Publication’

Cort Johnson: ‘Peterson’s Atypical Subset Opens New View of ME/CFS in Columbia/Simmaron Publication’

Cort Johnson writes a stunning breakdown on the recent research differentiating Atypical and Classical ME/CFS by scientists at Columbia CII and Simmaron Research The recent paper ‘Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical and classical presentations’ by Dr. Mady Hornig et al is a complex paper. Cort Johnson from Health Rising has done an excellentRead more about Cort Johnson: ‘Peterson’s Atypical Subset Opens New View of ME/CFS in Columbia/Simmaron Publication’[…]

New Research Discovers Evidence of Atypical & Classical ME/CFS

New Research Discovers Evidence of Atypical & Classical ME/CFS

This latest research is the first to report evidence differentiating Atypical and Classical ME/CFS The researchers measured 51 different cytokines (immune messenger molecules) in cerebrospinal fluid. Their immune network analysis of these cytokines provided evidence that Atypical and Classical cases of ME/CFS have differing immune signatures within the central nervous system. This work suggests distinct presentations and course of diseaseRead more about New Research Discovers Evidence of Atypical & Classical ME/CFS[…]

The ME/CFS Biomarker Rollercoaster

The ME/CFS Biomarker Rollercoaster

    Biomarkers are a holy grail for ME/CFS because they have the potential to help diagnose disease, track disease progression or progress and help inform which treatments might help. The need for biomarkers is immense and researchers will identify many possible ones. It is encouraging that there have been more possible biomarker reports recently. It canRead more about The ME/CFS Biomarker Rollercoaster[…]

ME/CFS Hits Nature News & A Call Out For An Urgent Advocacy Action!

ME/CFS Hits Nature News & A Call Out For An Urgent Advocacy Action!

It is wonderful to see an article in Nature covering emerging science in ME/CFS and quoting top scientists who are working on the disease. Not long ago in February, NewScientist featured a great piece and now Nature has published an excellent peice by Amy Maxemen, ‘Biological underpinnings of chronic fatigue syndrome begin to emerge’ with the sub-heading “Gut bacteria and altered metabolic pathways are suspects in mysterious disease.” IsRead more about ME/CFS Hits Nature News & A Call Out For An Urgent Advocacy Action![…]

NIH RFA’s! Money talks – what will this mean for Columbia CII’s ME/CFS research!?

NIH RFA’s! Money talks – what will this mean for Columbia CII’s ME/CFS research!?

The National Institutes of Health finally announced their Request for Applications for a funding opportunity for the first ever Data Management Center and Collaborative Research Centers for ME/CFS.   After decades of effort by people with ME/CFS, their families, advocates and researchers to get research dollars increased for ME/CFS, the much anticipated announcements finally came. With bated breathRead more about NIH RFA’s! Money talks – what will this mean for Columbia CII’s ME/CFS research!?[…]

News round up: Momentum is building for ME/CFS!

News round up: Momentum is building for ME/CFS!

Our Microbe Discovery Project team had some time unplugged through the holiday period but while we were away momentum was building in the ME/CFS research world! Straight off the bat there was some big news from Norway just before Christmas! Drs. Fluge and Mella et all AKA the Norwegian team, published a paper titled ‘Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronicRead more about News round up: Momentum is building for ME/CFS![…]